![]() ![]() The control group included asymptomatic participants who were recruited before the COVID-19 pandemic (prior to 2020) to serve as controls for other studies and included 1 asymptomatic participant who was enrolled in 2022 and had no history of COVID-19 illness, which was supported by a negative nucleocapsid antibody in the blood. Participants with neuro-PCC were enrolled in The COVID Mind Study at Yale University if they self-reported new or worsened neuropsychiatric symptoms at least 3 months after laboratory–confirmed COVID-19. This study followed reporting requirements of the Strengthening the Reporting of Observational Studies in Epidemiology ( STROBE) reporting guideline. All participants provided written informed consent. This case-control study was approved by the institutional review board at Yale University. Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment. ![]() Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |